These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 3025263
21. Clinical and immunological considerations in Epstein-Barr virus-associated diseases. Andersson J. Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357 [Abstract] [Full Text] [Related]
23. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus. Tanaka Y, Sugamura K, Hinuma Y. J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428 [Abstract] [Full Text] [Related]
25. Expression of mucin (MUC-1) from a mini-Epstein-Barr virus in immortalized B-cells to generate tumor antigen specific cytotoxic T cells. Kilger E, Pecher G, Schwenk A, Hammerschmidt W. J Gene Med; 1999 Mar; 1(2):84-92. PubMed ID: 10738572 [Abstract] [Full Text] [Related]
27. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis. Jondal M. Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222 [Abstract] [Full Text] [Related]
32. The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon. Thorley-Lawson DA. J Immunol; 1981 Mar; 126(3):829-33. PubMed ID: 6161964 [Abstract] [Full Text] [Related]
33. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell. Thorley-Lawson DA. J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331 [Abstract] [Full Text] [Related]
34. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide. Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y. Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491 [Abstract] [Full Text] [Related]
35. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells. Wasik M, Myc A, Matej H, Rudzka L. Arch Immunol Ther Exp (Warsz); 1983 Oct; 31(6):871-8. PubMed ID: 6331340 [Abstract] [Full Text] [Related]
37. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies. van de Griend RJ, Giphart MJ, Van Krimpen BA, Bolhuis RL. J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072 [Abstract] [Full Text] [Related]
38. CD8 lymphocytes during Epstein Barr virus (EBV) infection: A CD29 positive population is expanded in acute infectious mononucleosis. de Paoli P, Gennari D, Reitano M, Martelli P, Sacilotto C, Comoretto R, Santini G. Allergol Immunopathol (Madr); 1991 Sep; 19(2):95-7. PubMed ID: 1722959 [Abstract] [Full Text] [Related]